Global Anthelmintic Fenbendazole 麻豆原创 Research Report 2024

Publication ID:

PB503243027

Publication Date:

March 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Fenbendazole is a drug substance classified under the category 鈥楢nthelmintic Agent鈥� (for veterinary use) .It is used in the treatment & control of fluke infections of the digestive system caused by roundworms , tapeworms , hookworms , lungworms which are generally found in Cats , Sheeps, Goats ,Pet birds , Pigeons. Hence this drug is an effective de-wormer in animals.
The global Anthelmintic Fenbendazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anthelmintic Fenbendazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anthelmintic Fenbendazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anthelmintic Fenbendazole include Alivira Animal Health, Vaishali Pharma, Bazayan & Co, Rochem International, Jiangsu Baozong & Baoda Pharmachem, Shanxi Hanjiang pharmaceutical, Lasa Supergenerics Limited and Procyon Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anthelmintic Fenbendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthelmintic Fenbendazole.
Report Scope
The Anthelmintic Fenbendazole market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anthelmintic Fenbendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anthelmintic Fenbendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Alivira Animal Health
Vaishali Pharma
Bazayan & Co
Rochem International
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Supergenerics Limited
Procyon Life Sciences
Segment by Type
鈮�98%
鈮�99%
Other
Segment by Application
Fenbendazole Granule
Fenbendazole Powder
Fenbenazole Tablet
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anthelmintic Fenbendazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Anthelmintic Fenbendazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Anthelmintic Fenbendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Anthelmintic Fenbendazole 麻豆原创 Overview
1.1 Product Definition
1.2 Anthelmintic Fenbendazole Segment by Type
1.2.1 Global Anthelmintic Fenbendazole 麻豆原创 Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 鈮�98%
1.2.3 鈮�99%
1.2.4 Other
1.3 Anthelmintic Fenbendazole Segment by Application
1.3.1 Global Anthelmintic Fenbendazole 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Fenbendazole Granule
1.3.3 Fenbendazole Powder
1.3.4 Fenbenazole Tablet
1.3.5 Other
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Anthelmintic Fenbendazole Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Anthelmintic Fenbendazole Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Anthelmintic Fenbendazole Production Estimates and Forecasts (2019-2030)
1.4.4 Global Anthelmintic Fenbendazole 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Anthelmintic Fenbendazole Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Anthelmintic Fenbendazole Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Anthelmintic Fenbendazole, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Anthelmintic Fenbendazole 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Anthelmintic Fenbendazole Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Anthelmintic Fenbendazole, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Anthelmintic Fenbendazole, Product Offered and Application
2.8 Global Key Manufacturers of Anthelmintic Fenbendazole, Date of Enter into This Industry
2.9 Anthelmintic Fenbendazole 麻豆原创 Competitive Situation and Trends
2.9.1 Anthelmintic Fenbendazole 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Anthelmintic Fenbendazole Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Anthelmintic Fenbendazole Production by Region
3.1 Global Anthelmintic Fenbendazole Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Anthelmintic Fenbendazole Production Value by Region (2019-2030)
3.2.1 Global Anthelmintic Fenbendazole Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Anthelmintic Fenbendazole by Region (2025-2030)
3.3 Global Anthelmintic Fenbendazole Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Anthelmintic Fenbendazole Production by Region (2019-2030)
3.4.1 Global Anthelmintic Fenbendazole Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Anthelmintic Fenbendazole by Region (2025-2030)
3.5 Global Anthelmintic Fenbendazole 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Anthelmintic Fenbendazole Production and Value, Year-over-Year Growth
3.6.1 North America Anthelmintic Fenbendazole Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Anthelmintic Fenbendazole Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Anthelmintic Fenbendazole Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Anthelmintic Fenbendazole Production Value Estimates and Forecasts (2019-2030)
4 Anthelmintic Fenbendazole Consumption by Region
4.1 Global Anthelmintic Fenbendazole Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Anthelmintic Fenbendazole Consumption by Region (2019-2030)
4.2.1 Global Anthelmintic Fenbendazole Consumption by Region (2019-2024)
4.2.2 Global Anthelmintic Fenbendazole Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Anthelmintic Fenbendazole Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Anthelmintic Fenbendazole Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Anthelmintic Fenbendazole Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Anthelmintic Fenbendazole Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Anthelmintic Fenbendazole Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Anthelmintic Fenbendazole Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Anthelmintic Fenbendazole Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Anthelmintic Fenbendazole Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Anthelmintic Fenbendazole Production by Type (2019-2030)
5.1.1 Global Anthelmintic Fenbendazole Production by Type (2019-2024)
5.1.2 Global Anthelmintic Fenbendazole Production by Type (2025-2030)
5.1.3 Global Anthelmintic Fenbendazole Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Anthelmintic Fenbendazole Production Value by Type (2019-2030)
5.2.1 Global Anthelmintic Fenbendazole Production Value by Type (2019-2024)
5.2.2 Global Anthelmintic Fenbendazole Production Value by Type (2025-2030)
5.2.3 Global Anthelmintic Fenbendazole Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Anthelmintic Fenbendazole Price by Type (2019-2030)
6 Segment by Application
6.1 Global Anthelmintic Fenbendazole Production by Application (2019-2030)
6.1.1 Global Anthelmintic Fenbendazole Production by Application (2019-2024)
6.1.2 Global Anthelmintic Fenbendazole Production by Application (2025-2030)
6.1.3 Global Anthelmintic Fenbendazole Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Anthelmintic Fenbendazole Production Value by Application (2019-2030)
6.2.1 Global Anthelmintic Fenbendazole Production Value by Application (2019-2024)
6.2.2 Global Anthelmintic Fenbendazole Production Value by Application (2025-2030)
6.2.3 Global Anthelmintic Fenbendazole Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Anthelmintic Fenbendazole Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Alivira Animal Health
7.1.1 Alivira Animal Health Anthelmintic Fenbendazole Corporation Information
7.1.2 Alivira Animal Health Anthelmintic Fenbendazole Product Portfolio
7.1.3 Alivira Animal Health Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Alivira Animal Health Main Business and 麻豆原创s Served
7.1.5 Alivira Animal Health Recent Developments/Updates
7.2 Vaishali Pharma
7.2.1 Vaishali Pharma Anthelmintic Fenbendazole Corporation Information
7.2.2 Vaishali Pharma Anthelmintic Fenbendazole Product Portfolio
7.2.3 Vaishali Pharma Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Vaishali Pharma Main Business and 麻豆原创s Served
7.2.5 Vaishali Pharma Recent Developments/Updates
7.3 Bazayan & Co
7.3.1 Bazayan & Co Anthelmintic Fenbendazole Corporation Information
7.3.2 Bazayan & Co Anthelmintic Fenbendazole Product Portfolio
7.3.3 Bazayan & Co Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Bazayan & Co Main Business and 麻豆原创s Served
7.3.5 Bazayan & Co Recent Developments/Updates
7.4 Rochem International
7.4.1 Rochem International Anthelmintic Fenbendazole Corporation Information
7.4.2 Rochem International Anthelmintic Fenbendazole Product Portfolio
7.4.3 Rochem International Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Rochem International Main Business and 麻豆原创s Served
7.4.5 Rochem International Recent Developments/Updates
7.5 Jiangsu Baozong & Baoda Pharmachem
7.5.1 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Corporation Information
7.5.2 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Product Portfolio
7.5.3 Jiangsu Baozong & Baoda Pharmachem Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Jiangsu Baozong & Baoda Pharmachem Main Business and 麻豆原创s Served
7.5.5 Jiangsu Baozong & Baoda Pharmachem Recent Developments/Updates
7.6 Shanxi Hanjiang pharmaceutical
7.6.1 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Corporation Information
7.6.2 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Product Portfolio
7.6.3 Shanxi Hanjiang pharmaceutical Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Shanxi Hanjiang pharmaceutical Main Business and 麻豆原创s Served
7.6.5 Shanxi Hanjiang pharmaceutical Recent Developments/Updates
7.7 Lasa Supergenerics Limited
7.7.1 Lasa Supergenerics Limited Anthelmintic Fenbendazole Corporation Information
7.7.2 Lasa Supergenerics Limited Anthelmintic Fenbendazole Product Portfolio
7.7.3 Lasa Supergenerics Limited Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Lasa Supergenerics Limited Main Business and 麻豆原创s Served
7.7.5 Lasa Supergenerics Limited Recent Developments/Updates
7.8 Procyon Life Sciences
7.8.1 Procyon Life Sciences Anthelmintic Fenbendazole Corporation Information
7.8.2 Procyon Life Sciences Anthelmintic Fenbendazole Product Portfolio
7.8.3 Procyon Life Sciences Anthelmintic Fenbendazole Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Procyon Life Sciences Main Business and 麻豆原创s Served
7.7.5 Procyon Life Sciences Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Anthelmintic Fenbendazole Industry Chain Analysis
8.2 Anthelmintic Fenbendazole Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Anthelmintic Fenbendazole Production Mode & Process
8.4 Anthelmintic Fenbendazole Sales and 麻豆原创ing
8.4.1 Anthelmintic Fenbendazole Sales Channels
8.4.2 Anthelmintic Fenbendazole Distributors
8.5 Anthelmintic Fenbendazole Customers
9 Anthelmintic Fenbendazole 麻豆原创 Dynamics
9.1 Anthelmintic Fenbendazole Industry Trends
9.2 Anthelmintic Fenbendazole 麻豆原创 Drivers
9.3 Anthelmintic Fenbendazole 麻豆原创 Challenges
9.4 Anthelmintic Fenbendazole 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Alivira Animal Health
Vaishali Pharma
Bazayan & Co
Rochem International
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Supergenerics Limited
Procyon Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.